Akèy › Dyabèt Tip 2 › Texas › Austin
Etid klinik pou Dyabèt Tip 2 nan Austin, TX
12 etid pou Dyabèt Tip 2 ap chèche patisipan nan sit nan ak bò kote Austin (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Ap rekriteFaz 3
- Pinnacle Clinical Research - Austin, Austin
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
Ap rekriteFaz 3
- Texas Diabetes and Endocrinology - Central Austin, Austin
Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
Ap rekriteFaz 3
- Texas Diabetes & Endocrinology, Austin
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Ap rekriteFaz 3
- IMA Clinical Research Austin, Austin
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Ap rekriteFaz 3
- AURORA-2 Clinical Site, Austin
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
Ap rekriteFaz 2
- IMA Clinical Research, Austin
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Ap rekriteFaz 2
- Velocity Clinical Research, Austin, Austin
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
Ap rekriteFaz 3
- Elligo Clinical Research Center, Austin
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
Ap rekriteFaz 3
- Pinnacle Clinical Research, Austin
Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes
Ap rekrite
- Texas Diabetes & Endocrinology, Austin
Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
Ap rekrite
- Texas Diabetes and Endocrinology, Austin
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
Ap rekriteFaz 2
- Elligo Health Research, Inc., Austin
Etid Dyabèt Tip 2 nan lòt vil
- San Antonio, TX37 etid
- Houston, TX31 etid
- Orlando, FL24 etid
- Boston, MA20 etid
- Chicago, IL19 etid
- Dallas, TX19 etid
- Miami, FL19 etid
- Columbus, OH18 etid
- Las Vegas, NV18 etid
- Atlanta, GA17 etid
- San Diego, CA17 etid
- Los Angeles, CA16 etid
Lòt etid nan Austin
- Kansè Poumon ki pa ti selil30 etid
- Kansè (tout kalite)21 etid
- Obèsite20 etid
- Kansè kolorektal19 etid
- Kansè Metastatik19 etid
- Ensifizyans kadyak18 etid
- Sipwa18 etid
- Kansè nan tete18 etid
- Kansè ovè17 etid
- Kansè Endomèt16 etid
- Kansè pwostat15 etid
- Depresyon14 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.